- Home
- RPRX vs ALAB Comparison
RPRX vs ALAB Comparison
Compare RPRX & ALAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- ALAB
- Stock Information
- Founded
- RPRX 1996
- ALAB 2017
- Country
- RPRX United States
- ALAB United States
- Employees
- RPRX N/A
- ALAB N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- ALAB
- Sector
- RPRX Health Care
- ALAB
- Exchange
- RPRX Nasdaq
- ALAB NYSE
- Market Cap
- RPRX 14.2B
- ALAB 14.2B
- IPO Year
- RPRX 2020
- ALAB 2024
- Fundamental
- Price
- RPRX $32.20
- ALAB $66.11
- Analyst Decision
- RPRX Strong Buy
- ALAB Strong Buy
- Analyst Count
- RPRX 4
- ALAB 13
- Target Price
- RPRX $42.50
- ALAB $105.85
- AVG Volume (30 Days)
- RPRX 4.5M
- ALAB 3.9M
- Earning Date
- RPRX 05-08-2025
- ALAB 05-06-2025
- Dividend Yield
- RPRX 2.73%
- ALAB N/A
- EPS Growth
- RPRX N/A
- ALAB N/A
- EPS
- RPRX 1.91
- ALAB N/A
- Revenue
- RPRX $2,263,576,000.00
- ALAB $396,290,000.00
- Revenue This Year
- RPRX $31.56
- ALAB $72.55
- Revenue Next Year
- RPRX $5.94
- ALAB $31.71
- P/E Ratio
- RPRX $16.84
- ALAB N/A
- Revenue Growth
- RPRX N/A
- ALAB 242.24
- 52 Week Low
- RPRX $24.05
- ALAB $36.22
- 52 Week High
- RPRX $34.20
- ALAB $147.39
- Technical
- Relative Strength Index (RSI)
- RPRX 51.13
- ALAB N/A
- Support Level
- RPRX $31.58
- ALAB N/A
- Resistance Level
- RPRX $32.73
- ALAB N/A
- Average True Range (ATR)
- RPRX 0.93
- ALAB 0.00
- MACD
- RPRX 0.06
- ALAB 0.00
- Stochastic Oscillator
- RPRX 82.74
- ALAB 0.00
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About ALAB ASTERA LABS INC
Astera Labs Inc is a company that offers an Intelligent Connectivity Platform, comprised of Semiconductor-based, high-speed mixed-signal connectivity products that integrate a matrix of microcontrollers and sensors. COSMOS, their software suite which is embedded in its connectivity products and integrated into their customers' systems. The Company delivers critical connectivity performance, enables flexibility and customization, and supports observability and predictive analytics. This approach addresses the data, network, and memory bottlenecks, scalability, and other infrastructure requirements of hyperscalers and system original equipment manufacturers.